カテゴリー： RNCOS

ブラジルの医療市場展望

RNCOSが発行した調査報告書（RNCS60409）
◆英語タイトル：Brazil Healthcare Market Outlook 2020
◆商品コード：RNCS60409
◆発行会社（リサーチ会社）：RNCOS
◆発行日：2016年3月
◆ページ数：105
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：ブラジル
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）
Single UserUSD1,200 ⇒換算￥130,800見積依頼/購入/質問フォーム
Multi UserUSD1,800 ⇒換算￥196,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はRNCOS社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。RNCOS社の概要及び新刊レポートはこちらでご確認いただけます。

 【レポートの概要】

Brazil is considered as one of the most lucrative healthcare market in Latin America, with consistent ranking amongst the top five global destinations for medical tourism. The country attracts a variety of medical tourists to take advantage of the successful and world-renowned cosmetic surgery industry. Growing demand for private healthcare has helped fuel a boom in the sector, which remains dominated by local players and has recently witnessed a number of mergers as many seek to capitalize on higher demand and consolidate their positions.
According to our report, “Brazil Healthcare Market Outlook 2020”, with better standards of living, the healthcare expenditure in the country has been rising continuously which is driving the healthcare industry. Among the healthcare sectors, the pharmaceutical market in the country witnessed tremendous growth, especially Prescription drugs market that enjoyed lion’s share of nearly 50% in 2015. However, the generics drug segment is forecasted to do well in future. With several factors, such as increasing patent expiries and greater generic company involvement in Brazil, the segment is anticipated to be the main factor for growth of the pharmaceutical market in the country. Besides, innovation and improvements in the medical equipment sector have been consistent in Brazil.

Healthcare spending in the country is anticipated to grow at a CAGR of around 5.8% during 2016-2020. The main factors behind the high healthcare expenditure include the prevalence of various diseases in the country, like hypertension. Other major prevalent diseases covered in the report include cancer, tuberculosis, obesity and diabetes.

As per our findings, the future outlook of Brazil healthcare IT-industry is quite optimistic as the IT segment has witnessed significant mergers and acquisition in 2015. The world’s leading healthcare IT companies are also looking towards Brazil as an ideal destination for their business expansion. Brazil passed a new law allowing foreign companies to invest capital in private hospitals for the first time, a move expected to appeal to those eager to capitalize on high demand for private healthcare in the country, and bring much-needed funding to the sector. Investors from all over the globe are eager to invest in the country’s healthcare sector. For instance, India based drugmaker, Lupin, has acquired Medquímica Indústria Farmacêutica, a Brazilian branded generics and OTC maker, expanding its presence in Latin America through Brazil.

Our report provides an in-depth research and analysis of the key segments, namely Hospital Services Industry, Pharmaceutical Industry, Medical Devices Industry, Healthcare IT industry, and other emerging market segments. It also highlights the current industry trends; presenting the key driver and foreign investments to enable clients understand the market structure and its prospective during the forecasted period. The report also covers detailed information about the active market players in hospital services, pharmaceutical, medical devices and healthcare IT-sector.

【レポートの目次】

1. Analyst View
2. Research Methodology
3. Healthcare Market Overview
4. Market Trends and Drivers
4.1 Favorable Demographics
4.2 Epidemiology
4.2.1 Tuberculosis
4.2.2 Hypertension
4.2.3 Obesity
4.2.4 Diabetes
4.2.5 Cancer
4.3 Healthcare industry accelerated by Merger and Acquisition
4.4 Increased IT Penetration in Healthcare Industry
5. Healthcare Industry Outlook to 2020
5.1 Healthcare Infrastructure
5.1.1 Hospitals
5.1.2 Beds
5.1.3 Human Resource
5.2 Pharmaceutical Market
5.2.1 Prescription Drug
5.2.2 Generic Drugs
5.2.3 OTC Drugs
5.2.4 Import and Export
5.3 Medical Equipment Industry
5.4 Healthcare IT-Market
5.4.1 E-health
5.4.2 M-health
5.4.3 Telemedicine
5.4.4 Medical Imaging Information System
6. Market Opportunities
6.1 Health Insurance Industry
6.2 Medical Tourism Industry
6.3 Clinical Trials Industry
6.4 Biotech Industry
7. Regulatory Environment
8. Government Healthcare Programs
9. Competitive Landscape
9.1 Hospital Services
9.1.1 Group Hospital Conceição (GHC)
9.1.2 Rede D’Or Ltda.
9.1.3 The Albert Einstein Israeli Hospital (HIAE)
9.1.4 Universidade Federal do Maranhão (UFMA)
9.2 Pharmaceuticals
9.2.1 Sanofi-Aventis
9.2.2 Bayer
9.2.3 Novartis
9.2.4 Pfizer
9.3 Medical Equipment
9.3.1 GE Healthcare
9.3.2 Philips Healthcare
9.3.3 Air Liquide
9.3.4 Baxter
9.4 Healthcare IT
9.4.1 Agfa HealthCare
9.4.2 MV Sistemas
9.4.3 Wheb Sistemas SA
9.4.4 TOTVS

List of Figures:

Figure 3-1: Healthcare Expenditure (Billion US$), 2014-2020
Figure 3-2: Healthcare Spending Percentage of GDP in Comparison to Latin American Countries (2013)
Figure 4-1: Spending on Medicines by Age Group (%), 2015
Figure 4-2: Share of Different Diseases in Population (2015)
Figure 4-3: Percentage of Population Diagnosed with Hypertension (2011, 2015 & 2018)
Figure 4-4: Percentage of Population with Obesity (2011, 2015 & 2018)
Figure 4-5: Overweight Population by Gender (%), 2015
Figure 4-6: Percentage of Population with Diabetes (2011, 2015 & 2018)
Figure 5-1: Share of Public and Private Hospitals (2014)
Figure 5-2: Forecast for Share of Public and Private Hospitals (2020)
Figure 5-3: Number of Hospital Beds (’000), 2014-2020
Figure 5-4: Share of Public and Private Hospital Beds (2014)
Figure 5-5: Number of Doctors (‘000), 2014-2020
Figure 5-6: Number of Nurses (‘000), 2014-2020
Figure 5-7: Share of Brazilian Pharmaceutical Market in Latin America (2015)
Figure 5-8: Pharmaceutical Market (Billion BRL), 2014-2020
Figure 5-9: Pharmaceutical Market (Billion Units), 2014-2020
Figure 5-10: Pharmaceutical Market by Segment (%), 2015
Figure 5-11: Forecast for Pharmaceutical Market by Segment (%), 2020
Figure 5-12: Share of Domestic and Foreign Pharmaceutical Laboratories (2015)
Figure 5-13: Pharmaceutical Market by Region (%), 2015
Figure 5-14 : Prescription Drug Market (Billion BRL), 2014-2020
Figure 5-15: Prescription Drug Market (Million Units), 2014-2020
Figure 5-16: Generic Drugs Market (Billion BRL), 2014-2020
Figure 5-17: Generic Drugs Market (Million Units), 2014-2020
Figure 5-18: OTC Drug Market (Billion US$), 2014-2020
Figure 5-19: OTC Drugs Market (Million Units), 2014-2020
Figure 5-20: Pharmaceutical Imports (Billion US$), 2010-2013
Figure 5-21: Pharmaceutical Exports (Billion US$), 2010-2013
Figure 5-22: Medical Equipment Market (Billion US$), 2014-2020
Figure 5-23: Medical Equipment Imports (Billion US$), 2011, 2013 & 2014
Figure 5-24: Medical Equipment Exports (Million US$), 2011 & 2013
Figure 5-25: Healthcare IT Market (Billion US$), 2014-2020
Figure 5-26: E-health Market (Million US$), 2014-2020
Figure 5-27: M-health Market (Million US$), 2014-2020
Figure 5-28: Telemedicine Market (Million US$), 2014-2020
Figure 5-29: Medical Imaging Information System Market (Million US$), 2014-2020
Figure 5-30: Picture Archiving and Communications Systems (PACS) Market (Million US$), 2014-2020
Figure 6-1: Private Health Insurance Net Premium (Billion BRL), 2011-2014
Figure 6-2: Number of Clinical Studies (2011-2015)

List of Tables:

Table 4-1: Demographic Characteristics (2010-2016)
Table 5-1: Number of Healthcare Institutions (2014)
Table 5-2: Number of Public Hospital Network Working for SUS (2014)
Table 5-3: Share of Hospitals by Region (2014)
Table 5-4: Number of Doctors per Thousand Populations by Top Cities (2013)
Table 5-5: Market Share of Leading Pharmaceutical Companies (2013)
Table 5-6: Leading Drugs by Sales (Million US$), 2013
Table 5-7: Market Share of Leading Generic Drugs Companies (2013)
Table 8-1: Key Goals under Various Parts of UPA 24-hours Program



【免責事項】
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ ブラジルの医療市場展望(Brazil Healthcare Market Outlook 2020)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • サウジアラビアの医療市場（～2020） The Saudi Arabia has proven its leadership in regional healthcare sector, fuelled by increased government spending in healthcare, rise in population, increase in per capita income and growing healthcare projects. The government intends to significantly increase the quality of healthcare services in the country. As per our latest research report “Saudi Arabian Healthcare Outlook 2020”, the healthcare sector in the Kingdom is anticipated to expand at a CAGR of around 9% during the 2015-2020. On studying the market thoroughly, we observed the trends in play like government initiatives that are boosting the kingdom’s healthcare market. The study of the emerging...
  • UAEの医療市場展望 With rising initiatives by government, the UAE Healthcare market is witnessing an astonishing growth. This is due to sedentary lifestyle by the population of Emirates and growing medical tourism in the region. Also, the UAE government is extensively expanding and upgrading its healthcare system to develop strong world class healthcare infrastructure. The government is also encouraging private sector participation to upgrade the existing infrastructure and match the quality of services offered in developed countries. Further, the UAE Government is also liberalizing policies to attract foreign investments, in order to improvise the healthcare standard and boost the healthcare industry. Our holistic...
  • UAEのヘルスケア産業（医療・製薬）動向 The UAE Healthcare market is witnessing an astonishing growth. This is due to increasing number of diseases associated with lifestyle and growing medical tourism in the region. Strong demands for quality healthcare services and ever increasing rates of diseases have given a push to this healthcare sector. UAE is actively expanding its national healthcare system to meet the medical needs of its citizen. The UAE Government is also liberalizing policies to attract foreign investments, in order to improvise the healthcare standard and boost the healthcare industry. Our holistic research and analysis depicts that the healthcare market of UAE will grow...
  • 北米の在宅医療市場動向 US home healthcare industry has become one of the fastest growing sectors. An increasing number of aging population and government initiatives, shifted the expensive hospital care to the home. The prevalence of chronic diseases, growing physician acceptance of home healthcare, technological advancements and cost-effective treatment options from public and private payers have all fostered the industry growth. The home healthcare market is forecasted to grow at a CAGR of approximately 7% during 2015-2020. In latest research study, “US Home Healthcare Market Outlook 2020”, RNCOS’ analysts have identified the market dynamics and clearly highlight the areas offering promising possibilities for companies...
  • サウジアラビアの医療市場動向（～2022） Saudi Arabian healthcare sector caters to a rapidly growing population, and the concurrent increase in health issues is boosting the sector to flourish. Saudi Arabia is continuously investing in healthcare related projects in Kingdoms like Riyadh, Makkah, Jeddah, etc. for developing advance healthcare system in these regions. Moreover, the government is blending in the regulatory framework to attract more private investment in this sector. As per our latest research report “KSA Healthcare Market Outlook 2022”, the healthcare sector in the Kingdom is anticipated to expand at a CAGR of around 8% during the 2016-2022. With the rising number of public/private...
  • 米国のヘルスケアIT市場 The US Healthcare IT market is witnessing an astonishing growth as the country becomes the largest healthcare market across the globe and its rising healthcare cost becomes a foremost concern for the US government today. As a result, with stricter government regulations and increasing adoption of healthcare IT systems in hospitals, the industry is offering immense opportunities for new and existing players taking up the business. In their latest research study “US Healthcare IT Market Outlook 2020”, RNCOS’ analysts have identified and deciphered the market dynamics in important segments thus clearly highlighting the areas offering promising possibilities for companies to...
  • アメリカの臨床検査市場：検査種類別、ラボ種類別、疾患種類別分析 The US clinical laboratories are a full service reference laboratories performing routine and specialized diagnostic testing service for physicians and patients. US represents an attractive destination for healthcare services’ market segments, especially clinical lab testing, which has evolved as a major source of decisive factor for healthcare professionals and that too despite garnering a low proportion of total medical spending. It is estimated that the market for clinical lab testing in the US is poised to witness healthy growth backed by factors such as aging population, active private sector participation, and rising awareness level. With the emergence of new technologies,...
  • 核医学の世界市場動向：核医学診断、核医学治療 Nuclear Medicine is one of the most promising segments of the medical imaging industry; and is becoming increasingly popular for disease diagnosis and treatment due to safe, painless and cost effective procedures. The Nuclear Medicine has been witnessing a steady demand over the past few years, backed by the worldwide increase in the number of cancer and cardiovascular cases, increasing awareness about early disease detection, and an ever increasing ageing population. According to our research report, "Global Nuclear Medicine Outlook 2020”, the Global Nuclear Medicine market is anticipated to sustain a robust growth in the coming years also, growing at...
  • 米国のジェネリック医薬品市場 The US is the largest pharmaceutical market in the world. Driven by the factors such as large healthcare spending, high per-capita income, and strong research & development investments, the pharmaceutical market in the US has witnessed an upward surge over the past few years. Additionally, the share of Generics has increased steadily in the pharmaceutical market, in terms of both revenue and prescriptions. The US generic drugs market accounts for a share of around 45% in the global Generics market. This share has been growing at a fast pace on the back of factors, such as demand for cost-effective medications,...
  • インドのジェネリック医薬品市場 Generics drugs are bioequivalent versions of the originator medicines. These drugs are cheaper and offer similar health benefits as those of branded counterparts. Generics are showing high penetration in the pharma market across the globe. In India, these drugs account for nearly 75% of the pharma market. This is due to the factors, such as rising healthcare expenditure, ageing population, high incidences of obesity, diabetes and cardiovascular diseases, as well as ongoing patent cliff of blockbuster drugs in the US and European markets. India is a market dominated by branded generics. Approximately 80% of the generics are off-patented drugs sold...
  • アメリカの医療IT市場見通し2022 The US Healthcare IT market has witnessed a gradual shift owing to factors like government initiative programs, emergence of latest technology and strategic collaboration in the sectors among players. The stringent regulation followed by increasing adoption of healthcare IT system in hospital is reviving the healthcare IT market while encouraging the investments from existing and new players. The latest report “US Healthcare IT Market Outlook 2022” provides comprehensive insight on the industry by its segment and component. The component segment of US Healthcare IT industry is driven by HIT hardware followed by HIT services and HIT software. While the segment...
  • 喘息予防薬の世界市場動向 Asthma is showing high prevalence worldwide. About 300 Million people are suffering from asthma. This is due to continuously deteriorating air quality, which is causing several allergies. In recent years, researchers have explored wide variety of preventive drugs that can delay asthma attacks. These drugs are being highly acknowledged by the doctors and consumers. The practice of prescribing preventive drugs by doctors is gaining momentum in the US, Europe and Asia-Pacific. Foreseeing the demand, several pharma players are shifting their R&D focus towards preventive asthma drugs. Some of the leading players in the pharma industry include Glaxosmithkline, Astrazeneca, Merck, Novartis,...
  • 世界のウェアラブル医療機器市場 Wearable medical devices are non-invasive, autonomous health tools, which aid in clinical monitoring beyond the hospitals. The applications of wearables range from monitoring glucose levels in blood, to managing chronic diseases such as heart diseases, asthma and diabetes. These devices generally provide noninvasive sensing, local processing, user feedback, and communication capabilities. In the latest report, “Global Wearable Medical Device Market Outlook 2020”, RNCOS analysts have endeavored to showcase the potential of the Wearable Medical Devices industry. The market, which was valued at US$ 1.5 Billion in 2014, is expected to reach US$ 4.6 Billion in the next five years. Driven...
  • アメリカの糖尿病治療市場 Diabetes has been on the rise for the last few years because of factors such as increased life span of people, hectic lifestyles and increased intake of fatty food. The largest number of cases of diabetes and pre-diabetes are found in the United States, with many still unaware about their diabetes or pre-diabetes condition. It has been estimated that the prevalence of diabetes will be 14% by 2030 in the US. This is likely to put a major burden on healthcare cost of the country. Studies have shown that the total healthcare expenditure in US was US$ 281 Billion in...
  • ジェネリック医薬品の南アフリカ市場見通し2022 Access to therapeutic drugs form an integral part of any successful healthcare system. The high cost of drugs, however remains a barrier to accessibility and improved health to the majority of the South African population. The promotion of generic drug consumption was the answer to this issue, with its massive cost-saving mechanism in regard for the final consumers, insurance providers, and government. In 2001, the South African Government passed the law that allowed substitution of branded medicines with generic drugs, which in turn made South Africa a huge market space for the generic drug manufacturing pharmaceutical companies. Further, it is...

    • ◆H&Iグローバルリサーチのお客様（例）◆